Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib

BACKGROUND: Osteoblastic bone reaction (OBR) refers to an increase in bone density at the site of bone metastasis or the appearance of new sclerotic bone lesions after anticancer treatment. OBR can be misunderstood as disease progression. In this study, we aimed to investigate the prevalence and det...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaoka, Kensuke, Sumikawa, Hiromitsu, Oyamada, Shunsuke, Tamiya, Akihiro, Inagaki, Yuji, Taniguchi, Yoshihiko, Nakao, Keiko, Matsuda, Yoshinobu, Okishio, Kyoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481568/
https://www.ncbi.nlm.nih.gov/pubmed/37674153
http://dx.doi.org/10.1186/s12885-023-11360-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481568/
https://www.ncbi.nlm.nih.gov/pubmed/37674153
http://dx.doi.org/10.1186/s12885-023-11360-w

Ejemplares similares